Wisconsin alleges Mallinckrodt underpaid Medicaid rebates
Wisconsin joined a lawsuit last week against Ireland-based Mallinckrodt for allegedly failing to report and return hundreds of millions of dollars in overpayments by underpaying Medicaid drug rebates for a gel used to treat acute flares or relapses of multiple sclerosis.
To access this content, you must purchase a Premium membership, or log in if you are a member.
